'Oncology biosimilars' presentation slideshows

Global Oncology Biosimilars Market 2014-2018

Big Market Research has announced a new Report Package "Global Oncology Biosimilars Market -Size, Share, Trends, Forecast, Development, Situation, Future outlook, Potential" Get Complete Details At: http://www.bigmarketresearch.com/global-oncology-biosimilars-2014-2018-market Biosimilars are follow-on versions of biological medicines that are developed after the expiry of the patent protection on the original product. Biosimilar medicines have a mechanism of action that is similar to that of the original biological medicines. Though biosimilars have many similarities to the innovator product, they are not an exact copy of the reference biopharmaceutical product. Enquire At: http://www.bigmarketresearch.com/report-enquiry/169979

259 views • 7 slides

Global Oncology Biosimilars Market Forecast 2014-2018

Research analysts forecast the Global Oncology Biosimilars market to grow at a CAGR of 29.87 percent over the period 2013-2018. Biosimilars are follow-on versions of biological medicines that are developed after the expiry of the patent protection on the original product. Biosimilar medicines have a mechanism of action that is similar to that of the original biological medicines.

267 views • 6 slides

Global Oncology Biosimilars Market 2015 Industry Growth, Trends, Analysis, Research and Development

Gathering and collating accurate data about the global Oncology Biosimilars market Research 2015 can be a hard task for companies operating in the market, due to the large volume of data about the market. Sifting through the wide-ranging information can be a tough task, which is where this market research report comes into the picture. Prepared by expert analysts with years of experience and spot-on market judgment, the report is a must-have accessory for all participants in the Oncology Biosimilars market.

174 views • 6 slides

Rapid approval of biosimilars for oncology is expected to be a major driving factor for growth of the oncology biosimilars market over the forecast period.

50 views • 4 slides

Oncology Biosimilars Market Opportunity Analysis, 2018-2026

Biosimilar is a biological product that resembles a reference product and is not difference from the already approved reference product. These are relatively cheaper than branded or approved products. Several biologics for oncology have already lost their patents, and some are in its period of expiry. As more products are expected to lose patents, biosimilar is expected to gain popularity. Leading generic players such as Mylan N.V., Teva Pharmaceutical Industries Ltd, Allergan Plc, Sandoz (a Novartis International AG’s division) are expected to capitalize on these patent expiries and may establish themselves as dominating players in oncology biosimilars market.

63 views • 3 slides

Oncology Biosimilars Market Global Trends, and Forecast till 2026

Biosimilar is a biological product that resembles a reference product and is not difference from the already approved reference product.

51 views • 3 slides